PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU

Charlotte M. Verburgt  ¹     Katherine A Dunn  ²     Anthony R. Otley  ²     Melvin B. Heyman  ³     Sofia Verstraete  ³     Whitney M. Sunseri  ⁴     Francisco Sylvester  ⁵     Tim G. de Meij  ⁵     Andre M. Comeau  ⁵     Morgan Langille  ⁵     Wouter J. de Jonge  ⁶     Marc Benninga  ⁶     Johan E. Van Limbergen  ^6    
1 Amsterdam University Medical Centers - Loc. University of Amsterdam, Emma Children's Hospital, Amsterdam, Netherlands
² Dalhousie University, Halifax, Canada
³ UCSF Benioff Children’s Hospital, University of California, San Francisco, United States
⁴ UPMC Children’s Hospital of Pittsburgh, Pittsburgh, United States
⁵ UNC Children’s Hospital, University of North Carolina, Chapel Hill, United States
⁶ Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, Netherlands

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)